These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 28994284)
1. Gastro-Resistant Insulin Receptor-Binding Peptide from Momordica charantia Improved the Glucose Tolerance in Streptozotocin-Induced Diabetic Mice via Insulin Receptor Signaling Pathway. Lo HY; Li CC; Chen FY; Chen JC; Hsiang CY; Ho TY J Agric Food Chem; 2017 Oct; 65(42):9266-9274. PubMed ID: 28994284 [TBL] [Abstract][Full Text] [Related]
2. Identification of the bioactive and consensus peptide motif from Momordica charantia insulin receptor-binding protein. Lo HY; Li CC; Ho TY; Hsiang CY Food Chem; 2016 Aug; 204():298-305. PubMed ID: 26988505 [TBL] [Abstract][Full Text] [Related]
3. A novel insulin receptor-binding protein from Momordica charantia enhances glucose uptake and glucose clearance in vitro and in vivo through triggering insulin receptor signaling pathway. Lo HY; Ho TY; Li CC; Chen JC; Liu JJ; Hsiang CY J Agric Food Chem; 2014 Sep; 62(36):8952-61. PubMed ID: 25144709 [TBL] [Abstract][Full Text] [Related]
4. A gastro-resistant peptide from Liao PY; Lo HY; Liu IC; Lo LC; Hsiang CY; Ho TY Food Funct; 2022 Feb; 13(4):1822-1833. PubMed ID: 35083999 [TBL] [Abstract][Full Text] [Related]
5. Differential anti-diabetic effects and mechanism of action of charantin-rich extract of Taiwanese Momordica charantia between type 1 and type 2 diabetic mice. Wang HY; Kan WC; Cheng TJ; Yu SH; Chang LH; Chuu JJ Food Chem Toxicol; 2014 Jul; 69():347-56. PubMed ID: 24751968 [TBL] [Abstract][Full Text] [Related]
6. The novel anti-inflammatory activity of mcIRBP from Liao PY; Lo HY; Liu IC; Lo LC; Hsiang CY; Ho TY Food Funct; 2022 Feb; 13(3):1268-1279. PubMed ID: 35023522 [TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled trial to evaluate the hypoglycemic efficacy of the mcIRBP-19-containing Yang YS; Wu NY; Kornelius E; Huang CN; Yang NC Food Nutr Res; 2022; 66():. PubMed ID: 35140559 [TBL] [Abstract][Full Text] [Related]
8. Momordica charantia and its novel polypeptide regulate glucose homeostasis in mice via binding to insulin receptor. Lo HY; Ho TY; Lin C; Li CC; Hsiang CY J Agric Food Chem; 2013 Mar; 61(10):2461-8. PubMed ID: 23414136 [TBL] [Abstract][Full Text] [Related]
9. Momordica charantia Administration Improves Insulin Secretion in Type 2 Diabetes Mellitus. Cortez-Navarrete M; Martínez-Abundis E; Pérez-Rubio KG; González-Ortiz M; Méndez-Del Villar M J Med Food; 2018 Jul; 21(7):672-677. PubMed ID: 29431598 [TBL] [Abstract][Full Text] [Related]
10. Cucurbitane Triterpenoids from the Fruits of Momordica Charantia Improve Insulin Sensitivity and Glucose Homeostasis in Streptozotocin-Induced Diabetic Mice. Han JH; Tuan NQ; Park MH; Quan KT; Oh J; Heo KS; Na M; Myung CS Mol Nutr Food Res; 2018 Apr; 62(7):e1700769. PubMed ID: 29405623 [TBL] [Abstract][Full Text] [Related]
11. Slow acting protein extract from fruit pulp of Momordica charantia with insulin secretagogue and insulinomimetic activities. Yibchok-anun S; Adisakwattana S; Yao CY; Sangvanich P; Roengsumran S; Hsu WH Biol Pharm Bull; 2006 Jun; 29(6):1126-31. PubMed ID: 16755004 [TBL] [Abstract][Full Text] [Related]
12. Antidiabetic activities of a cucurbitane‑type triterpenoid compound from Momordica charantia in alloxan‑induced diabetic mice. Jiang B; Ji M; Liu W; Chen L; Cai Z; Zhao Y; Bi X Mol Med Rep; 2016 Nov; 14(5):4865-4872. PubMed ID: 27748816 [TBL] [Abstract][Full Text] [Related]
13. Momordica charantia reverses type II diabetes in rat. Malekshahi H; Bahrami G; Miraghaee S; Ahmadi SA; Sajadimajd S; Hatami R; Mohammadi B; Keshavarzi S J Food Biochem; 2019 Nov; 43(11):e13021. PubMed ID: 31441956 [TBL] [Abstract][Full Text] [Related]
14. Beneficial effects and mechanism of action of Momordica charantia juice in the treatment of streptozotocin-induced diabetes mellitus in rat. Ahmed I; Adeghate E; Cummings E; Sharma AK; Singh J Mol Cell Biochem; 2004 Jun; 261(1-2):63-70. PubMed ID: 15362486 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of selenylated polysaccharides from Momordica charantia L. and its hypoglycemic activity in streptozotocin-induced diabetic mice. Ru Y; Liu K; Kong X; Li X; Shi X; Chen H Int J Biol Macromol; 2020 Jun; 152():295-304. PubMed ID: 32112833 [TBL] [Abstract][Full Text] [Related]
17. Synergistic antidiabetic activity of Taraxacum officinale (L.) Weber ex F.H.Wigg and Momordica charantia L. polyherbal combination. Perumal N; Nallappan M; Shohaimi S; Kassim NK; Tee TT; Cheah YH Biomed Pharmacother; 2022 Jan; 145():112401. PubMed ID: 34785415 [TBL] [Abstract][Full Text] [Related]
18. Momordica charantia extracts ameliorate insulin resistance by regulating the expression of SOCS-3 and JNK in type 2 diabetes mellitus rats. Ma C; Yu H; Xiao Y; Wang H Pharm Biol; 2017 Dec; 55(1):2170-2177. PubMed ID: 29110587 [TBL] [Abstract][Full Text] [Related]
19. Suppressive activity of the fruit of Momordica charantia with exercise on blood glucose in type 2 diabetic mice. Miura T; Itoh Y; Iwamoto N; Kato M; Ishida T Biol Pharm Bull; 2004 Feb; 27(2):248-50. PubMed ID: 14758046 [TBL] [Abstract][Full Text] [Related]
20. The soybean peptide aglycin regulates glucose homeostasis in type 2 diabetic mice via IR/IRS1 pathway. Lu J; Zeng Y; Hou W; Zhang S; Li L; Luo X; Xi W; Chen Z; Xiang M J Nutr Biochem; 2012 Nov; 23(11):1449-57. PubMed ID: 22278080 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]